Treatment with cisplatin or dabigatran etexilate individually did not alter the levels of TGF-β and VEGF in the ascites of ID8 tumor bearing mice (Figure 5); however, co-treatment with both significantly reduced levels of both TGF-β and VEGF. Here, TGFB1 is linked to neoplasm.